Developing a predictive signature for two trial endpoints using the cross-validated risk scores method
{{output}}
The existing cross-validated risk scores (CVRS) design has been proposed for developing and testing the efficacy of a treatment in a high-efficacy patient group (the sensitive group) using high-dimensional data (such as genetic data). The design is based on co... ...
